76
Participants
Start Date
January 31, 2004
Primary Completion Date
November 30, 2010
Study Completion Date
December 31, 2011
atorvastatin and pioglitazone
atorvastatin 80 mg orally once daily (to reduce inflammation) and pioglitazone 30 mg orally once daily (to improve insulin sensitivity)
atorvastatin/placebo
atorvastatin 80 mg orally once daily and matching placebo orally twice daily
pioglitazone/placebo
pioglitazone 30 mg orally once daily and matching placebo orally once daily
placebo/placebo
placebo orally three times daily
Brigham & Women's Hospital, Boston
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Brigham and Women's Hospital
OTHER